Logos Global Management LP Sage Therapeutics, Inc. Transaction History

Logos Global Management LP

  • $1.07 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$58.41 - $89.06 $14.6 Million - $22.3 Million
-250,000 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$41.13 - $62.45 $10.3 Million - $15.6 Million
250,000 New
250,000 $15.3 Million
Q2 2020

Aug 14, 2020
SELL
$25.95 - $43.15 $1.81 Million - $3 Million
-69,591 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$26.15 - $77.24 $3.15 Million - $9.31 Million
-120,559 Reduced 63.4%
69,591 $2 Million
Q4 2019

Feb 14, 2020
BUY
$60.18 - $154.77 $11.4 Million - $29.4 Million
190,150 New
190,150 $13.7 Million

Others Institutions Holding SAGE

# of Institutions
217
Shares Held
48.2M
Call Options Held
854K
Put Options Held
195K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $469M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email